Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer

被引：10
作者：
Ingle, James N. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
BREAST CANCER RESEARCH | 2008年 / 10卷 / Suppl 4期
关键词：
D O I：
10.1186/bcr2177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 28 条
[1]   Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism:: Implication for optimization of breast cancer treatment [J].
Borges, Silvana ;
Desta, Zeruesenay ;
Li, Lang ;
Skaar, Todd C. ;
Ward, Bryan A. ;
Nguyen, Anne ;
Jin, Yan ;
Storniolo, Anna Maria ;
Nikoloff, D. Michele ;
Wu, Lin ;
Hillman, Grant ;
Hayes, Daniel F. ;
Stearns, Vered ;
Flockhart, David A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (01) :61-74
[2]   Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: Prominent roles for CYP3A and CYP2D6 [J].
Desta, Z ;
Ward, BA ;
Soukhova, NV ;
Flockhart, DA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03) :1062-1075
[3]   The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen [J].
Goetz, Matthew P. ;
Knox, Stacey K. ;
Suman, Vera J. ;
Rae, James M. ;
Safgren, Stephanie L. ;
Ames, Matthew M. ;
Visscher, Daniel W. ;
Reynolds, Carol ;
Couch, Fergus J. ;
Lingle, Wilma L. ;
Weinshilboum, Richard M. ;
Fritcher, Emily G. Barr ;
Nibbe, Andrea M. ;
Desta, Zeruesenay ;
Nguyen, Anne ;
Flockhart, David A. ;
Perez, Edith A. ;
Ingle, James N. .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 101 (01) :113-121
[4]   Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes [J].
Goetz, MP ;
Rae, JM ;
Suman, VJ ;
Safgren, SL ;
Ames, MM ;
Visscher, DW ;
Reynolds, C ;
Couch, FJ ;
Lingle, WL ;
Flockhart, DA ;
Desta, Z ;
Perez, EA ;
Ingle, JN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9312-9318
[5]   Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity [J].
Ingelman-Sundberg, M .
PHARMACOGENOMICS JOURNAL, 2005, 5 (01) :6-13
[6]   Pharmacogenomics of tamoxifen and aromatase inhibitors [J].
Ingle, James N. .
CANCER, 2008, 112 (03) :695-699
[7]   Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52 [J].
Ingle, James N. ;
Suman, Vera J. ;
Mailliard, James A. ;
Kugler, John W. ;
Krook, James E. ;
Michalak, John C. ;
Pisansky, Thomas M. ;
Wold, Lester E. ;
Donohue, John H. ;
Goetz, Matthew P. ;
Perez, Edith A. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 98 (02) :217-222
[8]  
Ingle JN, 1999, CLIN CANCER RES, V5, P1642
[9]   Adjuvant endocrine therapy for postmenopausal women with early breast cancer [J].
Ingle, JN .
CLINICAL CANCER RESEARCH, 2006, 12 (03) :1031S-1036S
[10]   Aromatase inhibitors for therapy of advanced breast cancer [J].
Ingle, JN ;
Suman, VJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 95 (1-5) :113-119
123